Biotechnology1 is one of the most important industries in a knowledge-based
economy. Governments are eager to develop the microbial biotechnology industry
to improve the skill levels of their workforce, to build up the R&D base for the
future of their economies, and to prosper as regional hubs in the era of globalization
(Burns, 2005). The development agenda has particular significance to countries
that must transform their economies to knowledge-based economies for the future.
However, challenges to latecomers in the field are formidable. In sum, microbial
biotechnology is characterized by high-risk, long-term development and lengthy
commercialization periods (Orsenigo, 1989).
Development in microbial biotechnology industry basically rests on the
advancements in life sciences (Orsenigo, 1989; Mangematin et al., 2003; and
Shahi, 2004). While, on the one hand, innovative activities in microbial
biotechnology require strong R&D efforts in life science which is widely dispersed
such that firms must interact with a relatively large number of scientific institutions
and firms to get the information they need (Orsenigo, 1989; and Powell et al.,
1996), on the other hand, a large number of innovators, mainly SMEs, characterizes the microbial biotechnology industry. The originality and range of technology based
on the life sciences encourage the emergence of new companies, and as a
consequence, the development of the microbial biotechnology sector is based on
the emergence of a large number of SMEs (Orsenigo, 1989; and Mangematin
et al., 2003).
|